Literature DB >> 14706218

Perineurial cell basement membrane thickening and myelinated nerve fibre loss in diabetic and nondiabetic peripheral nerve.

Rebecca E Hill1, Pamela E Williams.   

Abstract

Diabetic neuropathy is associated with changes in the extracellular matrix of the perineurium, including thickening of the basement membrane of the perineurial cells. Peripheral vascular disease (PVD) is a common vascular condition that can occur in the absence or presence of diabetes. Thickening of the vascular basement membrane of the vasa nervorum is associated with both diabetes and nondiabetic peripheral vascular disease. However, perineurial cell basement membrane (PCBM) thickening in the nondiabetic PVD state has not, until now, been investigated. In this study, 36 nerve fascicles were examined from three patient groups: a diabetic group, a nondiabetic PVD group, and a group free of both PVD and diabetes (control group). PCBM thickness, fascicle size, and myelinated nerve fibre (MNF) density were measured in all three groups. Endoneurial blood vessels were also observed for evidence of morphological changes. The results showed that the thickness of the PCBM is significantly greater in the diabetic group in comparison with both the control and the nondiabetic PVD group, and this increase in thickness is linearly related to fascicle size. The thickness of the PCBM was not significantly different between the nondiabetic PVD and control groups. Although both the nondiabetic PVD and diabetic groups showed a loss of myelinated nerve fibres in comparison with the control group, this loss was statistically greater in the diabetic group. The endoneurial blood vessels of both the diabetic and nondiabetic PVD groups showed evidence of endothelial cell hyperplasia, hypertrophy, and basement membrane reduplication.

Entities:  

Mesh:

Year:  2004        PMID: 14706218     DOI: 10.1016/j.jns.2003.09.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Temporal course of streptozotocin-induced diabetic polyneuropathy in rats.

Authors:  Yee-Fun Lee; Chou-Ching K Lin; Gin-Shin Chen
Journal:  Neurol Sci       Date:  2014-06-13       Impact factor: 3.307

2.  Deficiency in monocarboxylate transporter 1 (MCT1) in mice delays regeneration of peripheral nerves following sciatic nerve crush.

Authors:  Brett M Morrison; Akivaga Tsingalia; Svetlana Vidensky; Youngjin Lee; Lin Jin; Mohamed H Farah; Sylvain Lengacher; Pierre J Magistretti; Luc Pellerin; Jeffrey D Rothstein
Journal:  Exp Neurol       Date:  2014-10-29       Impact factor: 5.330

3.  Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction.

Authors:  Reyna L VanGilder; Jason D Huber
Journal:  Postdoc J       Date:  2014-07

4.  Extracellular matrix remodelling in human diabetic neuropathy.

Authors:  Rebecca Hill
Journal:  J Anat       Date:  2009-02       Impact factor: 2.610

5.  Morphometric analysis of connective tissue sheaths of sural nerve in diabetic and nondiabetic patients.

Authors:  Braca Kundalić; Slađana Ugrenović; Ivan Jovanović; Natalija Stefanović; Vladimir Petrović; Jasen Kundalić; Vesna Stojanović; Vladimir Živković; Vladimir Antić
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

6.  Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline: Implications for nerve regeneration.

Authors:  Sumia Ali; Heather E Driscoll; Victoria L Newton; Natalie J Gardiner
Journal:  Exp Neurol       Date:  2014-08-23       Impact factor: 5.330

7.  Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus.

Authors:  Dae Young Yoo; Hee Sun Yim; Hyo Young Jung; Sung Min Nam; Jong Whi Kim; Jung Hoon Choi; Je Kyung Seong; Yeo Sung Yoon; Dae Won Kim; In Koo Hwang
Journal:  J Vet Med Sci       Date:  2016-02-15       Impact factor: 1.267

8.  Benfotiamine reduced collagen IV contents of sciatic nerve in hyperglycemic rats.

Authors:  Leila Vafadar Ghasemi; Morteza Behnam Rassouli; Maryam M Matin; Naser Mahdavi-Shahri
Journal:  J Diabetes Metab Disord       Date:  2021-02-20

9.  Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy.

Authors:  Adel Ben-Kraiem; Reine-Solange Sauer; Carla Norwig; Maria Popp; Anna-Lena Bettenhausen; Mariam Sobhy Atalla; Alexander Brack; Robert Blum; Kathrin Doppler; Heike Lydia Rittner
Journal:  J Mol Med (Berl)       Date:  2021-05-21       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.